Pedro Colmenarez, Author at Inflammatix

September 4, 2025

Publication demonstrates superior analytical performance of TriVerity in assessing patients with suspected acute infection or sepsis Inflammatix, a pioneering host…

July 24, 2025

International multi-cohort analysis identifies novel framework for quantifying immune dysregulation in critical illness: results of the SUBSPACE consortium International multi-cohort analysis identifies novel framework for quantifying immune dysregulation in critical illness: results of the SUBSPACE consortium

May 8, 2025

Moore, A. et al. bioRxiv. Nov 2024. Pre-Print

May 6, 2025

April 2, 2025

March 25, 2025

The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) purchases TriVerity Test System to evaluate for…

February 6, 2025

January 21, 2025

January 21, 2025

January 21, 2025

Author: Pedro Colmenarez